MR308 (tramadol/celecoxib)

tramadol/celecoxib · Mundipharma Research GmbH & Co KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MR308 (tramadol/celecoxib), covering 2018-05-29 to 2018-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety in a Randomised Acute Pain Study of MR308 (Tramadol/Celecoxib). [Phase 3]